NAFCILLIN SODIUM
Substance profile for UNII 49G3001BCK, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 23704143Substance Identity#
- UNII
- 49G3001BCK
- Preferred term
- NAFCILLIN SODIUM
- Registry number
- 7177-50-6
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C21H21N2O5S.Na.H2O
Chemical And Database Identifiers#
- InChIKey
- OCXSDHJRMYFTMA-KMFBOIRUSA-M
- SMILES
- O.[Na+].CCOC1=CC=C2C=CC=CC2=C1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C([O-])=O
- RxCUI
- 485026
- PubChem
- 23704143
- NCIt
- C29281
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | Nafcillin for Injection, USP | 2 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 15 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN SODIUM INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 13 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 13 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 13 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN SODIUM INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 13 | |
| nafcillin sodium | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 9 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 8 | |
| nafcillin sodium | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 7 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] | 5 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] | 5 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN INJECTION, POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 3 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 3 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) POWDER, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 2 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 2 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] | 1 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN (NAFCILLIN SODIUM) INJECTION, POWDER, FOR SOLUTION [AUROMEDICS PHARMA LLC] | 1 | |
| NAFCILLIN SODIUM | ACTIVE INGREDIENT | 49G3001BCK | NAFCILLIN SODIUM INJECTION, POWDER, FOR SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 1 | |